nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—EGFR—brain cancer	0.313	1	CbGaD
Docetaxel—CYP1B1—Procarbazine—brain cancer	0.167	0.439	CbGbCtD
Docetaxel—ABCC10—Etoposide—brain cancer	0.063	0.166	CbGbCtD
Docetaxel—ABCC1—Etoposide—brain cancer	0.0243	0.0641	CbGbCtD
Docetaxel—ABCC2—Carboplatin—brain cancer	0.0214	0.0566	CbGbCtD
Docetaxel—ABCG2—Carboplatin—brain cancer	0.0194	0.0511	CbGbCtD
Docetaxel—ABCC2—Etoposide—brain cancer	0.018	0.0475	CbGbCtD
Docetaxel—CYP3A4—Temozolomide—brain cancer	0.0171	0.0451	CbGbCtD
Docetaxel—ABCG2—Etoposide—brain cancer	0.0163	0.0429	CbGbCtD
Docetaxel—CYP3A4—Lomustine—brain cancer	0.0146	0.0384	CbGbCtD
Docetaxel—CYP3A5—Etoposide—brain cancer	0.00902	0.0238	CbGbCtD
Docetaxel—ABCB1—Etoposide—brain cancer	0.00587	0.0155	CbGbCtD
Docetaxel—GHRHR—hindbrain—brain cancer	0.00372	0.051	CbGeAlD
Docetaxel—CYP3A4—Etoposide—brain cancer	0.00352	0.00927	CbGbCtD
Docetaxel—MAP2—telencephalic ventricle—brain cancer	0.00243	0.0333	CbGeAlD
Docetaxel—KIF11—Teniposide—Etoposide—brain cancer	0.00221	1	CbGdCrCtD
Docetaxel—GHRHR—brainstem—brain cancer	0.00213	0.0292	CbGeAlD
Docetaxel—GHRHR—pituitary gland—brain cancer	0.00154	0.0211	CbGeAlD
Docetaxel—MAP2—ganglion—brain cancer	0.00151	0.0207	CbGeAlD
Docetaxel—MAP4—hindbrain—brain cancer	0.00146	0.02	CbGeAlD
Docetaxel—Paclitaxel—CYP2C9—brain cancer	0.00144	1	CrCbGaD
Docetaxel—GHRHR—endocrine gland—brain cancer	0.00119	0.0164	CbGeAlD
Docetaxel—GHRHR—head—brain cancer	0.00118	0.0161	CbGeAlD
Docetaxel—MAP2—hindbrain—brain cancer	0.00115	0.0157	CbGeAlD
Docetaxel—GHRHR—central nervous system—brain cancer	0.00107	0.0147	CbGeAlD
Docetaxel—GHRHR—cerebellum—brain cancer	0.00105	0.0144	CbGeAlD
Docetaxel—MAPT—telencephalon—brain cancer	0.000943	0.0129	CbGeAlD
Docetaxel—TUBB4A—hindbrain—brain cancer	0.000887	0.0122	CbGeAlD
Docetaxel—GHRHR—brain—brain cancer	0.000853	0.0117	CbGeAlD
Docetaxel—MAP4—brainstem—brain cancer	0.000835	0.0114	CbGeAlD
Docetaxel—MAPT—pituitary gland—brain cancer	0.000768	0.0105	CbGeAlD
Docetaxel—MAP4—telencephalon—brain cancer	0.000741	0.0102	CbGeAlD
Docetaxel—MAPT—medulla oblongata—brain cancer	0.000741	0.0102	CbGeAlD
Docetaxel—KIF11—brain—brain cancer	0.000726	0.00995	CbGeAlD
Docetaxel—NR1I2—endocrine gland—brain cancer	0.000715	0.0098	CbGeAlD
Docetaxel—NR1I2—head—brain cancer	0.000705	0.00967	CbGeAlD
Docetaxel—MAPT—midbrain—brain cancer	0.000677	0.00928	CbGeAlD
Docetaxel—TUBB8—head—brain cancer	0.000676	0.00927	CbGeAlD
Docetaxel—BCL2—telencephalon—brain cancer	0.000674	0.00924	CbGeAlD
Docetaxel—EGFR—telencephalon—brain cancer	0.000666	0.00913	CbGeAlD
Docetaxel—MAPT—spinal cord—brain cancer	0.00066	0.00905	CbGeAlD
Docetaxel—MAP2—brainstem—brain cancer	0.000658	0.00902	CbGeAlD
Docetaxel—MAP4—gonad—brain cancer	0.000619	0.00848	CbGeAlD
Docetaxel—TUBB8—central nervous system—brain cancer	0.000617	0.00846	CbGeAlD
Docetaxel—MAP2—telencephalon—brain cancer	0.000584	0.008	CbGeAlD
Docetaxel—MAP4—medulla oblongata—brain cancer	0.000582	0.00798	CbGeAlD
Docetaxel—BCL2—gonad—brain cancer	0.000562	0.00771	CbGeAlD
Docetaxel—MAP4—midbrain—brain cancer	0.000532	0.0073	CbGeAlD
Docetaxel—SLCO1B3—pituitary gland—brain cancer	0.000528	0.00724	CbGeAlD
Docetaxel—MAPT—cerebellum—brain cancer	0.000524	0.00718	CbGeAlD
Docetaxel—MAP4—spinal cord—brain cancer	0.000519	0.00712	CbGeAlD
Docetaxel—TUBB4A—brainstem—brain cancer	0.000508	0.00697	CbGeAlD
Docetaxel—TUBB8—brain—brain cancer	0.00049	0.00672	CbGeAlD
Docetaxel—MAP2—gonad—brain cancer	0.000487	0.00668	CbGeAlD
Docetaxel—MAP2—pituitary gland—brain cancer	0.000475	0.00651	CbGeAlD
Docetaxel—MAP4—endocrine gland—brain cancer	0.000467	0.00641	CbGeAlD
Docetaxel—MAP4—head—brain cancer	0.000461	0.00633	CbGeAlD
Docetaxel—TUBB3—head—brain cancer	0.000461	0.00633	CbGeAlD
Docetaxel—MAP2—medulla oblongata—brain cancer	0.000459	0.00629	CbGeAlD
Docetaxel—TUBB1—head—brain cancer	0.000451	0.00619	CbGeAlD
Docetaxel—TUBB4A—telencephalon—brain cancer	0.000451	0.00618	CbGeAlD
Docetaxel—TUBB2B—telencephalon—brain cancer	0.000436	0.00598	CbGeAlD
Docetaxel—MAPT—brain—brain cancer	0.000425	0.00583	CbGeAlD
Docetaxel—BCL2—endocrine gland—brain cancer	0.000425	0.00583	CbGeAlD
Docetaxel—TUBB3—central nervous system—brain cancer	0.000421	0.00578	CbGeAlD
Docetaxel—MAP4—central nervous system—brain cancer	0.000421	0.00578	CbGeAlD
Docetaxel—BCL2—head—brain cancer	0.00042	0.00575	CbGeAlD
Docetaxel—MAP2—midbrain—brain cancer	0.000419	0.00575	CbGeAlD
Docetaxel—TUBB—telencephalon—brain cancer	0.000412	0.00566	CbGeAlD
Docetaxel—TUBB1—central nervous system—brain cancer	0.000412	0.00565	CbGeAlD
Docetaxel—TUBB3—cerebellum—brain cancer	0.000412	0.00564	CbGeAlD
Docetaxel—MAP4—cerebellum—brain cancer	0.000412	0.00564	CbGeAlD
Docetaxel—TUBB2A—telencephalon—brain cancer	0.00041	0.00563	CbGeAlD
Docetaxel—SLCO1B3—endocrine gland—brain cancer	0.000409	0.00561	CbGeAlD
Docetaxel—MAP2—spinal cord—brain cancer	0.000409	0.00561	CbGeAlD
Docetaxel—BCL2—central nervous system—brain cancer	0.000383	0.00525	CbGeAlD
Docetaxel—TUBB4A—gonad—brain cancer	0.000376	0.00516	CbGeAlD
Docetaxel—EGFR—cerebellum—brain cancer	0.00037	0.00507	CbGeAlD
Docetaxel—MAP2—endocrine gland—brain cancer	0.000368	0.00505	CbGeAlD
Docetaxel—TUBB2B—gonad—brain cancer	0.000364	0.00499	CbGeAlD
Docetaxel—MAP2—head—brain cancer	0.000363	0.00498	CbGeAlD
Docetaxel—TUBB2B—pituitary gland—brain cancer	0.000355	0.00487	CbGeAlD
Docetaxel—TUBB4A—medulla oblongata—brain cancer	0.000354	0.00486	CbGeAlD
Docetaxel—ABCC10—telencephalon—brain cancer	0.000354	0.00486	CbGeAlD
Docetaxel—TUBB4B—telencephalon—brain cancer	0.000352	0.00482	CbGeAlD
Docetaxel—CYP3A7—endocrine gland—brain cancer	0.000345	0.00473	CbGeAlD
Docetaxel—TUBB2B—medulla oblongata—brain cancer	0.000342	0.0047	CbGeAlD
Docetaxel—TUBB6—gonad—brain cancer	0.000338	0.00463	CbGeAlD
Docetaxel—TUBB—pituitary gland—brain cancer	0.000336	0.0046	CbGeAlD
Docetaxel—MAP4—brain—brain cancer	0.000334	0.00458	CbGeAlD
Docetaxel—TUBB3—brain—brain cancer	0.000334	0.00458	CbGeAlD
Docetaxel—TUBB2A—pituitary gland—brain cancer	0.000334	0.00458	CbGeAlD
Docetaxel—MAP2—central nervous system—brain cancer	0.000332	0.00455	CbGeAlD
Docetaxel—TUBB6—pituitary gland—brain cancer	0.00033	0.00452	CbGeAlD
Docetaxel—TUBB1—brain—brain cancer	0.000327	0.00448	CbGeAlD
Docetaxel—MAP2—cerebellum—brain cancer	0.000324	0.00444	CbGeAlD
Docetaxel—TUBB—medulla oblongata—brain cancer	0.000324	0.00444	CbGeAlD
Docetaxel—TUBB4A—midbrain—brain cancer	0.000324	0.00444	CbGeAlD
Docetaxel—TUBB2A—medulla oblongata—brain cancer	0.000322	0.00442	CbGeAlD
Docetaxel—SLC22A7—endocrine gland—brain cancer	0.000318	0.00436	CbGeAlD
Docetaxel—TUBB6—medulla oblongata—brain cancer	0.000318	0.00436	CbGeAlD
Docetaxel—TUBB4A—spinal cord—brain cancer	0.000316	0.00433	CbGeAlD
Docetaxel—TUBB2B—midbrain—brain cancer	0.000313	0.00429	CbGeAlD
Docetaxel—TUBB2B—spinal cord—brain cancer	0.000305	0.00419	CbGeAlD
Docetaxel—BCL2—brain—brain cancer	0.000304	0.00417	CbGeAlD
Docetaxel—EGFR—brain—brain cancer	0.0003	0.00412	CbGeAlD
Docetaxel—TUBB—midbrain—brain cancer	0.000296	0.00406	CbGeAlD
Docetaxel—ABCC10—gonad—brain cancer	0.000296	0.00405	CbGeAlD
Docetaxel—TUBB2A—midbrain—brain cancer	0.000295	0.00404	CbGeAlD
Docetaxel—TUBB4B—gonad—brain cancer	0.000294	0.00402	CbGeAlD
Docetaxel—TUBB6—midbrain—brain cancer	0.000291	0.00398	CbGeAlD
Docetaxel—TUBB—spinal cord—brain cancer	0.000289	0.00396	CbGeAlD
Docetaxel—ABCC10—pituitary gland—brain cancer	0.000289	0.00396	CbGeAlD
Docetaxel—TUBB2A—spinal cord—brain cancer	0.000287	0.00394	CbGeAlD
Docetaxel—TUBB4B—pituitary gland—brain cancer	0.000286	0.00393	CbGeAlD
Docetaxel—TUBB4A—endocrine gland—brain cancer	0.000284	0.0039	CbGeAlD
Docetaxel—TUBB6—spinal cord—brain cancer	0.000284	0.00389	CbGeAlD
Docetaxel—TUBB4A—head—brain cancer	0.000281	0.00385	CbGeAlD
Docetaxel—CYP1B1—telencephalon—brain cancer	0.000279	0.00382	CbGeAlD
Docetaxel—ABCC10—medulla oblongata—brain cancer	0.000278	0.00382	CbGeAlD
Docetaxel—TUBB4B—medulla oblongata—brain cancer	0.000276	0.00379	CbGeAlD
Docetaxel—TUBB2B—endocrine gland—brain cancer	0.000275	0.00377	CbGeAlD
Docetaxel—TUBB2B—head—brain cancer	0.000271	0.00372	CbGeAlD
Docetaxel—MAP2—brain—brain cancer	0.000263	0.00361	CbGeAlD
Docetaxel—TUBB2A—endocrine gland—brain cancer	0.000259	0.00355	CbGeAlD
Docetaxel—TUBB4A—central nervous system—brain cancer	0.000256	0.00351	CbGeAlD
Docetaxel—TUBB2A—head—brain cancer	0.000255	0.0035	CbGeAlD
Docetaxel—TUBB6—endocrine gland—brain cancer	0.000255	0.0035	CbGeAlD
Docetaxel—ABCC10—midbrain—brain cancer	0.000254	0.00349	CbGeAlD
Docetaxel—TUBB4B—midbrain—brain cancer	0.000253	0.00346	CbGeAlD
Docetaxel—TUBB6—head—brain cancer	0.000252	0.00345	CbGeAlD
Docetaxel—ABCC1—telencephalon—brain cancer	0.000251	0.00344	CbGeAlD
Docetaxel—TUBB4A—cerebellum—brain cancer	0.000251	0.00343	CbGeAlD
Docetaxel—ABCC10—spinal cord—brain cancer	0.000248	0.0034	CbGeAlD
Docetaxel—TUBB2B—central nervous system—brain cancer	0.000248	0.0034	CbGeAlD
Docetaxel—TUBB4B—spinal cord—brain cancer	0.000246	0.00338	CbGeAlD
Docetaxel—TUBB2B—cerebellum—brain cancer	0.000242	0.00332	CbGeAlD
Docetaxel—TUBB2A—central nervous system—brain cancer	0.000233	0.0032	CbGeAlD
Docetaxel—CYP1B1—gonad—brain cancer	0.000233	0.00319	CbGeAlD
Docetaxel—TUBB6—central nervous system—brain cancer	0.00023	0.00315	CbGeAlD
Docetaxel—TUBB—cerebellum—brain cancer	0.000229	0.00314	CbGeAlD
Docetaxel—TUBB2A—cerebellum—brain cancer	0.000228	0.00313	CbGeAlD
Docetaxel—SLC22A7—brain—brain cancer	0.000228	0.00312	CbGeAlD
Docetaxel—CYP1B1—pituitary gland—brain cancer	0.000227	0.00311	CbGeAlD
Docetaxel—TUBB6—cerebellum—brain cancer	0.000225	0.00308	CbGeAlD
Docetaxel—ABCC10—endocrine gland—brain cancer	0.000223	0.00306	CbGeAlD
Docetaxel—TUBB4B—endocrine gland—brain cancer	0.000222	0.00304	CbGeAlD
Docetaxel—TUBB4B—head—brain cancer	0.000219	0.003	CbGeAlD
Docetaxel—ABCB1—blood vessel—brain cancer	0.000211	0.00289	CbGeAlD
Docetaxel—ABCG2—telencephalon—brain cancer	0.000207	0.00284	CbGeAlD
Docetaxel—ABCC1—pituitary gland—brain cancer	0.000204	0.0028	CbGeAlD
Docetaxel—TUBB4A—brain—brain cancer	0.000204	0.00279	CbGeAlD
Docetaxel—TUBB4B—central nervous system—brain cancer	0.0002	0.00274	CbGeAlD
Docetaxel—ABCC10—cerebellum—brain cancer	0.000197	0.0027	CbGeAlD
Docetaxel—TUBB2B—brain—brain cancer	0.000197	0.0027	CbGeAlD
Docetaxel—TUBB4B—cerebellum—brain cancer	0.000195	0.00268	CbGeAlD
Docetaxel—TUBB—brain—brain cancer	0.000186	0.00255	CbGeAlD
Docetaxel—TUBB2A—brain—brain cancer	0.000185	0.00254	CbGeAlD
Docetaxel—TUBB6—brain—brain cancer	0.000183	0.0025	CbGeAlD
Docetaxel—ABCC2—endocrine gland—brain cancer	0.000179	0.00246	CbGeAlD
Docetaxel—CYP1B1—endocrine gland—brain cancer	0.000176	0.00241	CbGeAlD
Docetaxel—CYP1B1—head—brain cancer	0.000174	0.00238	CbGeAlD
Docetaxel—ABCG2—pituitary gland—brain cancer	0.000169	0.00232	CbGeAlD
Docetaxel—Pneumonia—Temozolomide—brain cancer	0.000167	0.00115	CcSEcCtD
Docetaxel—Anorexia—Procarbazine—brain cancer	0.000167	0.00115	CcSEcCtD
Docetaxel—Erythema—Hydroxyurea—brain cancer	0.000166	0.00115	CcSEcCtD
Docetaxel—Infestation NOS—Temozolomide—brain cancer	0.000166	0.00114	CcSEcCtD
Docetaxel—Infestation—Temozolomide—brain cancer	0.000166	0.00114	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000165	0.00113	CcSEcCtD
Docetaxel—Nausea—Lomustine—brain cancer	0.000164	0.00113	CcSEcCtD
Docetaxel—Hypotension—Procarbazine—brain cancer	0.000164	0.00113	CcSEcCtD
Docetaxel—ABCG2—medulla oblongata—brain cancer	0.000163	0.00223	CbGeAlD
Docetaxel—Neuropathy peripheral—Temozolomide—brain cancer	0.000163	0.00112	CcSEcCtD
Docetaxel—Stomatitis—Temozolomide—brain cancer	0.000162	0.00112	CcSEcCtD
Docetaxel—ABCC10—brain—brain cancer	0.00016	0.00219	CbGeAlD
Docetaxel—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00016	0.0011	CcSEcCtD
Docetaxel—TUBB4B—brain—brain cancer	0.000159	0.00218	CbGeAlD
Docetaxel—Insomnia—Procarbazine—brain cancer	0.000158	0.00109	CcSEcCtD
Docetaxel—CYP1B1—central nervous system—brain cancer	0.000158	0.00217	CbGeAlD
Docetaxel—Paraesthesia—Procarbazine—brain cancer	0.000157	0.00108	CcSEcCtD
Docetaxel—Hepatobiliary disease—Temozolomide—brain cancer	0.000157	0.00108	CcSEcCtD
Docetaxel—Somnolence—Procarbazine—brain cancer	0.000156	0.00107	CcSEcCtD
Docetaxel—Cramp muscle—Etoposide—brain cancer	0.000155	0.00107	CcSEcCtD
Docetaxel—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000155	0.00107	CcSEcCtD
Docetaxel—Haemoglobin—Carmustine—brain cancer	0.000155	0.00107	CcSEcCtD
Docetaxel—CYP1B1—cerebellum—brain cancer	0.000155	0.00212	CbGeAlD
Docetaxel—Haemorrhage—Carmustine—brain cancer	0.000154	0.00106	CcSEcCtD
Docetaxel—Anaemia—Hydroxyurea—brain cancer	0.000154	0.00106	CcSEcCtD
Docetaxel—Hypoaesthesia—Carmustine—brain cancer	0.000153	0.00106	CcSEcCtD
Docetaxel—Decreased appetite—Procarbazine—brain cancer	0.000152	0.00105	CcSEcCtD
Docetaxel—Alanine aminotransferase increased—Etoposide—brain cancer	0.000152	0.00105	CcSEcCtD
Docetaxel—Oedema peripheral—Carmustine—brain cancer	0.000152	0.00105	CcSEcCtD
Docetaxel—Connective tissue disorder—Carmustine—brain cancer	0.000152	0.00104	CcSEcCtD
Docetaxel—Fatigue—Procarbazine—brain cancer	0.000151	0.00104	CcSEcCtD
Docetaxel—Haemoglobin—Temozolomide—brain cancer	0.00015	0.00103	CcSEcCtD
Docetaxel—Constipation—Procarbazine—brain cancer	0.00015	0.00103	CcSEcCtD
Docetaxel—Pain—Procarbazine—brain cancer	0.00015	0.00103	CcSEcCtD
Docetaxel—Haemorrhage—Temozolomide—brain cancer	0.000149	0.00103	CcSEcCtD
Docetaxel—Hepatitis—Temozolomide—brain cancer	0.000149	0.00103	CcSEcCtD
Docetaxel—Dysphagia—Etoposide—brain cancer	0.000149	0.00103	CcSEcCtD
Docetaxel—ABCG2—midbrain—brain cancer	0.000149	0.00204	CbGeAlD
Docetaxel—Leukopenia—Hydroxyurea—brain cancer	0.000149	0.00102	CcSEcCtD
Docetaxel—Visual impairment—Carmustine—brain cancer	0.000149	0.00102	CcSEcCtD
Docetaxel—Hypoaesthesia—Temozolomide—brain cancer	0.000148	0.00102	CcSEcCtD
Docetaxel—Pharyngitis—Temozolomide—brain cancer	0.000148	0.00102	CcSEcCtD
Docetaxel—Urinary tract disorder—Temozolomide—brain cancer	0.000147	0.00101	CcSEcCtD
Docetaxel—Oedema peripheral—Temozolomide—brain cancer	0.000147	0.00101	CcSEcCtD
Docetaxel—Bronchospasm—Etoposide—brain cancer	0.000147	0.00101	CcSEcCtD
Docetaxel—Connective tissue disorder—Temozolomide—brain cancer	0.000146	0.00101	CcSEcCtD
Docetaxel—Urethral disorder—Temozolomide—brain cancer	0.000146	0.00101	CcSEcCtD
Docetaxel—ABCG2—spinal cord—brain cancer	0.000145	0.00199	CbGeAlD
Docetaxel—Feeling abnormal—Procarbazine—brain cancer	0.000144	0.000995	CcSEcCtD
Docetaxel—Eye disorder—Carmustine—brain cancer	0.000144	0.000994	CcSEcCtD
Docetaxel—Convulsion—Hydroxyurea—brain cancer	0.000144	0.000992	CcSEcCtD
Docetaxel—Visual impairment—Temozolomide—brain cancer	0.000144	0.00099	CcSEcCtD
Docetaxel—Gastrointestinal pain—Procarbazine—brain cancer	0.000143	0.000987	CcSEcCtD
Docetaxel—Flushing—Carmustine—brain cancer	0.000143	0.000987	CcSEcCtD
Docetaxel—Pancytopenia—Etoposide—brain cancer	0.000142	0.000976	CcSEcCtD
Docetaxel—Erythema multiforme—Temozolomide—brain cancer	0.000141	0.000972	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00014	0.000968	CcSEcCtD
Docetaxel—Neutropenia—Etoposide—brain cancer	0.000139	0.000961	CcSEcCtD
Docetaxel—Eye disorder—Temozolomide—brain cancer	0.000139	0.00096	CcSEcCtD
Docetaxel—ABCC1—cerebellum—brain cancer	0.000139	0.00191	CbGeAlD
Docetaxel—Abdominal pain—Procarbazine—brain cancer	0.000138	0.000955	CcSEcCtD
Docetaxel—Body temperature increased—Procarbazine—brain cancer	0.000138	0.000955	CcSEcCtD
Docetaxel—Cardiac disorder—Temozolomide—brain cancer	0.000138	0.000954	CcSEcCtD
Docetaxel—Flushing—Temozolomide—brain cancer	0.000138	0.000954	CcSEcCtD
Docetaxel—Arrhythmia—Carmustine—brain cancer	0.000138	0.00095	CcSEcCtD
Docetaxel—Alopecia—Carmustine—brain cancer	0.000136	0.00094	CcSEcCtD
Docetaxel—Oedema—Hydroxyurea—brain cancer	0.000136	0.000934	CcSEcCtD
Docetaxel—Angiopathy—Temozolomide—brain cancer	0.000135	0.000932	CcSEcCtD
Docetaxel—Mental disorder—Carmustine—brain cancer	0.000135	0.000932	CcSEcCtD
Docetaxel—Infection—Hydroxyurea—brain cancer	0.000135	0.000928	CcSEcCtD
Docetaxel—Immune system disorder—Temozolomide—brain cancer	0.000135	0.000928	CcSEcCtD
Docetaxel—Mediastinal disorder—Temozolomide—brain cancer	0.000134	0.000926	CcSEcCtD
Docetaxel—Erythema—Carmustine—brain cancer	0.000134	0.000926	CcSEcCtD
Docetaxel—Malnutrition—Carmustine—brain cancer	0.000134	0.000926	CcSEcCtD
Docetaxel—Chills—Temozolomide—brain cancer	0.000134	0.000922	CcSEcCtD
Docetaxel—Pneumonia—Etoposide—brain cancer	0.000134	0.000921	CcSEcCtD
Docetaxel—Nervous system disorder—Hydroxyurea—brain cancer	0.000133	0.000916	CcSEcCtD
Docetaxel—Infestation—Etoposide—brain cancer	0.000133	0.000916	CcSEcCtD
Docetaxel—Infestation NOS—Etoposide—brain cancer	0.000133	0.000916	CcSEcCtD
Docetaxel—Thrombocytopenia—Hydroxyurea—brain cancer	0.000133	0.000915	CcSEcCtD
Docetaxel—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000132	0.000908	CcSEcCtD
Docetaxel—Alopecia—Temozolomide—brain cancer	0.000132	0.000908	CcSEcCtD
Docetaxel—Skin disorder—Hydroxyurea—brain cancer	0.000132	0.000908	CcSEcCtD
Docetaxel—Acute coronary syndrome—Etoposide—brain cancer	0.000131	0.000903	CcSEcCtD
Docetaxel—Renal failure—Etoposide—brain cancer	0.000131	0.0009	CcSEcCtD
Docetaxel—Mental disorder—Temozolomide—brain cancer	0.000131	0.0009	CcSEcCtD
Docetaxel—Neuropathy peripheral—Etoposide—brain cancer	0.00013	0.000898	CcSEcCtD
Docetaxel—Myocardial infarction—Etoposide—brain cancer	0.00013	0.000898	CcSEcCtD
Docetaxel—Back pain—Carmustine—brain cancer	0.00013	0.000895	CcSEcCtD
Docetaxel—Malnutrition—Temozolomide—brain cancer	0.00013	0.000895	CcSEcCtD
Docetaxel—Erythema—Temozolomide—brain cancer	0.00013	0.000895	CcSEcCtD
Docetaxel—Jaundice—Etoposide—brain cancer	0.00013	0.000893	CcSEcCtD
Docetaxel—Stomatitis—Etoposide—brain cancer	0.00013	0.000893	CcSEcCtD
Docetaxel—Anorexia—Hydroxyurea—brain cancer	0.000129	0.000891	CcSEcCtD
Docetaxel—Hypersensitivity—Procarbazine—brain cancer	0.000129	0.00089	CcSEcCtD
Docetaxel—Dysgeusia—Temozolomide—brain cancer	0.000127	0.000876	CcSEcCtD
Docetaxel—CYP1B1—brain—brain cancer	0.000126	0.00172	CbGeAlD
Docetaxel—Asthenia—Procarbazine—brain cancer	0.000126	0.000866	CcSEcCtD
Docetaxel—Hepatobiliary disease—Etoposide—brain cancer	0.000126	0.000866	CcSEcCtD
Docetaxel—Back pain—Temozolomide—brain cancer	0.000126	0.000865	CcSEcCtD
Docetaxel—Anaemia—Carmustine—brain cancer	0.000124	0.000856	CcSEcCtD
Docetaxel—Agranulocytosis—Etoposide—brain cancer	0.000124	0.000855	CcSEcCtD
Docetaxel—Pruritus—Procarbazine—brain cancer	0.000124	0.000854	CcSEcCtD
Docetaxel—CYP3A5—endocrine gland—brain cancer	0.000121	0.00167	CbGeAlD
Docetaxel—Dyspnoea—Hydroxyurea—brain cancer	0.000121	0.000833	CcSEcCtD
Docetaxel—Somnolence—Hydroxyurea—brain cancer	0.000121	0.000831	CcSEcCtD
Docetaxel—Leukopenia—Carmustine—brain cancer	0.00012	0.000829	CcSEcCtD
Docetaxel—Anaemia—Temozolomide—brain cancer	0.00012	0.000827	CcSEcCtD
Docetaxel—Diarrhoea—Procarbazine—brain cancer	0.00012	0.000826	CcSEcCtD
Docetaxel—Dyspepsia—Hydroxyurea—brain cancer	0.000119	0.000823	CcSEcCtD
Docetaxel—Hypoaesthesia—Etoposide—brain cancer	0.000119	0.000818	CcSEcCtD
Docetaxel—Decreased appetite—Hydroxyurea—brain cancer	0.000118	0.000812	CcSEcCtD
Docetaxel—Urinary tract disorder—Etoposide—brain cancer	0.000118	0.000812	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000117	0.000807	CcSEcCtD
Docetaxel—Urethral disorder—Etoposide—brain cancer	0.000117	0.000806	CcSEcCtD
Docetaxel—Fatigue—Hydroxyurea—brain cancer	0.000117	0.000806	CcSEcCtD
Docetaxel—Convulsion—Carmustine—brain cancer	0.000116	0.000802	CcSEcCtD
Docetaxel—Leukopenia—Temozolomide—brain cancer	0.000116	0.000801	CcSEcCtD
Docetaxel—Hypertension—Carmustine—brain cancer	0.000116	0.000799	CcSEcCtD
Docetaxel—Constipation—Hydroxyurea—brain cancer	0.000116	0.000799	CcSEcCtD
Docetaxel—Pain—Hydroxyurea—brain cancer	0.000116	0.000799	CcSEcCtD
Docetaxel—Dizziness—Procarbazine—brain cancer	0.000116	0.000798	CcSEcCtD
Docetaxel—ABCG2—cerebellum—brain cancer	0.000115	0.00158	CbGeAlD
Docetaxel—Palpitations—Temozolomide—brain cancer	0.000115	0.00079	CcSEcCtD
Docetaxel—Myalgia—Carmustine—brain cancer	0.000114	0.000788	CcSEcCtD
Docetaxel—Chest pain—Carmustine—brain cancer	0.000114	0.000788	CcSEcCtD
Docetaxel—Cough—Temozolomide—brain cancer	0.000113	0.000781	CcSEcCtD
Docetaxel—ABCC1—brain—brain cancer	0.000113	0.00155	CbGeAlD
Docetaxel—Erythema multiforme—Etoposide—brain cancer	0.000113	0.000777	CcSEcCtD
Docetaxel—Convulsion—Temozolomide—brain cancer	0.000112	0.000775	CcSEcCtD
Docetaxel—Hypertension—Temozolomide—brain cancer	0.000112	0.000772	CcSEcCtD
Docetaxel—Feeling abnormal—Hydroxyurea—brain cancer	0.000112	0.00077	CcSEcCtD
Docetaxel—Eye disorder—Etoposide—brain cancer	0.000111	0.000768	CcSEcCtD
Docetaxel—Vomiting—Procarbazine—brain cancer	0.000111	0.000768	CcSEcCtD
Docetaxel—Flushing—Etoposide—brain cancer	0.000111	0.000763	CcSEcCtD
Docetaxel—Cardiac disorder—Etoposide—brain cancer	0.000111	0.000763	CcSEcCtD
Docetaxel—Confusional state—Carmustine—brain cancer	0.000111	0.000762	CcSEcCtD
Docetaxel—Myalgia—Temozolomide—brain cancer	0.00011	0.000762	CcSEcCtD
Docetaxel—Arthralgia—Temozolomide—brain cancer	0.00011	0.000762	CcSEcCtD
Docetaxel—Rash—Procarbazine—brain cancer	0.00011	0.000761	CcSEcCtD
Docetaxel—Dermatitis—Procarbazine—brain cancer	0.00011	0.000761	CcSEcCtD
Docetaxel—Headache—Procarbazine—brain cancer	0.00011	0.000756	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00011	0.000756	CcSEcCtD
Docetaxel—Oedema—Carmustine—brain cancer	0.00011	0.000755	CcSEcCtD
Docetaxel—Infection—Carmustine—brain cancer	0.000109	0.000751	CcSEcCtD
Docetaxel—Angiopathy—Etoposide—brain cancer	0.000108	0.000746	CcSEcCtD
Docetaxel—Dry mouth—Temozolomide—brain cancer	0.000108	0.000745	CcSEcCtD
Docetaxel—Immune system disorder—Etoposide—brain cancer	0.000108	0.000743	CcSEcCtD
Docetaxel—Mediastinal disorder—Etoposide—brain cancer	0.000108	0.000741	CcSEcCtD
Docetaxel—Thrombocytopenia—Carmustine—brain cancer	0.000107	0.00074	CcSEcCtD
Docetaxel—Body temperature increased—Hydroxyurea—brain cancer	0.000107	0.000739	CcSEcCtD
Docetaxel—Chills—Etoposide—brain cancer	0.000107	0.000738	CcSEcCtD
Docetaxel—Tachycardia—Carmustine—brain cancer	0.000107	0.000737	CcSEcCtD
Docetaxel—Confusional state—Temozolomide—brain cancer	0.000107	0.000736	CcSEcCtD
Docetaxel—Oedema—Temozolomide—brain cancer	0.000106	0.00073	CcSEcCtD
Docetaxel—Anaphylactic shock—Temozolomide—brain cancer	0.000106	0.00073	CcSEcCtD
Docetaxel—Alopecia—Etoposide—brain cancer	0.000105	0.000727	CcSEcCtD
Docetaxel—Infection—Temozolomide—brain cancer	0.000105	0.000725	CcSEcCtD
Docetaxel—Anorexia—Carmustine—brain cancer	0.000104	0.00072	CcSEcCtD
Docetaxel—Nausea—Procarbazine—brain cancer	0.000104	0.000717	CcSEcCtD
Docetaxel—Nervous system disorder—Temozolomide—brain cancer	0.000104	0.000716	CcSEcCtD
Docetaxel—Thrombocytopenia—Temozolomide—brain cancer	0.000104	0.000715	CcSEcCtD
Docetaxel—Skin disorder—Temozolomide—brain cancer	0.000103	0.000709	CcSEcCtD
Docetaxel—Hypotension—Carmustine—brain cancer	0.000102	0.000706	CcSEcCtD
Docetaxel—ABCB1—telencephalon—brain cancer	0.000102	0.0014	CbGeAlD
Docetaxel—Dysgeusia—Etoposide—brain cancer	0.000102	0.000701	CcSEcCtD
Docetaxel—Anorexia—Temozolomide—brain cancer	0.000101	0.000696	CcSEcCtD
Docetaxel—Back pain—Etoposide—brain cancer	0.0001	0.000692	CcSEcCtD
Docetaxel—Hypersensitivity—Hydroxyurea—brain cancer	9.99e-05	0.000688	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Carmustine—brain cancer	9.98e-05	0.000688	CcSEcCtD
Docetaxel—Muscle spasms—Etoposide—brain cancer	9.98e-05	0.000688	CcSEcCtD
Docetaxel—Insomnia—Carmustine—brain cancer	9.91e-05	0.000683	CcSEcCtD
Docetaxel—Paraesthesia—Carmustine—brain cancer	9.84e-05	0.000678	CcSEcCtD
Docetaxel—Dyspnoea—Carmustine—brain cancer	9.77e-05	0.000674	CcSEcCtD
Docetaxel—Somnolence—Carmustine—brain cancer	9.74e-05	0.000672	CcSEcCtD
Docetaxel—Asthenia—Hydroxyurea—brain cancer	9.73e-05	0.00067	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Temozolomide—brain cancer	9.65e-05	0.000665	CcSEcCtD
Docetaxel—Anaemia—Etoposide—brain cancer	9.6e-05	0.000662	CcSEcCtD
Docetaxel—Insomnia—Temozolomide—brain cancer	9.58e-05	0.00066	CcSEcCtD
Docetaxel—Decreased appetite—Carmustine—brain cancer	9.53e-05	0.000657	CcSEcCtD
Docetaxel—Paraesthesia—Temozolomide—brain cancer	9.51e-05	0.000656	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Carmustine—brain cancer	9.46e-05	0.000652	CcSEcCtD
Docetaxel—Dyspnoea—Temozolomide—brain cancer	9.44e-05	0.000651	CcSEcCtD
Docetaxel—Somnolence—Temozolomide—brain cancer	9.42e-05	0.000649	CcSEcCtD
Docetaxel—Constipation—Carmustine—brain cancer	9.37e-05	0.000646	CcSEcCtD
Docetaxel—Pain—Carmustine—brain cancer	9.37e-05	0.000646	CcSEcCtD
Docetaxel—ABCG2—brain—brain cancer	9.36e-05	0.00128	CbGeAlD
Docetaxel—Dyspepsia—Temozolomide—brain cancer	9.32e-05	0.000643	CcSEcCtD
Docetaxel—Leukopenia—Etoposide—brain cancer	9.29e-05	0.000641	CcSEcCtD
Docetaxel—Diarrhoea—Hydroxyurea—brain cancer	9.28e-05	0.000639	CcSEcCtD
Docetaxel—Decreased appetite—Temozolomide—brain cancer	9.21e-05	0.000635	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Temozolomide—brain cancer	9.14e-05	0.00063	CcSEcCtD
Docetaxel—Fatigue—Temozolomide—brain cancer	9.13e-05	0.000629	CcSEcCtD
Docetaxel—Loss of consciousness—Etoposide—brain cancer	9.13e-05	0.000629	CcSEcCtD
Docetaxel—CYP3A4—endocrine gland—brain cancer	9.12e-05	0.00125	CbGeAlD
Docetaxel—Cough—Etoposide—brain cancer	9.06e-05	0.000625	CcSEcCtD
Docetaxel—Pain—Temozolomide—brain cancer	9.06e-05	0.000624	CcSEcCtD
Docetaxel—Constipation—Temozolomide—brain cancer	9.06e-05	0.000624	CcSEcCtD
Docetaxel—Feeling abnormal—Carmustine—brain cancer	9.03e-05	0.000623	CcSEcCtD
Docetaxel—Convulsion—Etoposide—brain cancer	9e-05	0.00062	CcSEcCtD
Docetaxel—Hypertension—Etoposide—brain cancer	8.97e-05	0.000618	CcSEcCtD
Docetaxel—Dizziness—Hydroxyurea—brain cancer	8.96e-05	0.000618	CcSEcCtD
Docetaxel—Gastrointestinal pain—Carmustine—brain cancer	8.96e-05	0.000618	CcSEcCtD
Docetaxel—Chest pain—Etoposide—brain cancer	8.84e-05	0.000609	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	8.78e-05	0.000605	CcSEcCtD
Docetaxel—Feeling abnormal—Temozolomide—brain cancer	8.73e-05	0.000602	CcSEcCtD
Docetaxel—Abdominal pain—Carmustine—brain cancer	8.66e-05	0.000597	CcSEcCtD
Docetaxel—Body temperature increased—Carmustine—brain cancer	8.66e-05	0.000597	CcSEcCtD
Docetaxel—Gastrointestinal pain—Temozolomide—brain cancer	8.66e-05	0.000597	CcSEcCtD
Docetaxel—Vomiting—Hydroxyurea—brain cancer	8.62e-05	0.000594	CcSEcCtD
Docetaxel—Rash—Hydroxyurea—brain cancer	8.55e-05	0.000589	CcSEcCtD
Docetaxel—Confusional state—Etoposide—brain cancer	8.55e-05	0.000589	CcSEcCtD
Docetaxel—Dermatitis—Hydroxyurea—brain cancer	8.54e-05	0.000589	CcSEcCtD
Docetaxel—ABCB1—gonad—brain cancer	8.54e-05	0.00117	CbGeAlD
Docetaxel—Headache—Hydroxyurea—brain cancer	8.49e-05	0.000585	CcSEcCtD
Docetaxel—Anaphylactic shock—Etoposide—brain cancer	8.47e-05	0.000584	CcSEcCtD
Docetaxel—Infection—Etoposide—brain cancer	8.42e-05	0.00058	CcSEcCtD
Docetaxel—Body temperature increased—Temozolomide—brain cancer	8.37e-05	0.000577	CcSEcCtD
Docetaxel—Abdominal pain—Temozolomide—brain cancer	8.37e-05	0.000577	CcSEcCtD
Docetaxel—ABCB1—pituitary gland—brain cancer	8.33e-05	0.00114	CbGeAlD
Docetaxel—Thrombocytopenia—Etoposide—brain cancer	8.3e-05	0.000572	CcSEcCtD
Docetaxel—Tachycardia—Etoposide—brain cancer	8.27e-05	0.00057	CcSEcCtD
Docetaxel—Skin disorder—Etoposide—brain cancer	8.23e-05	0.000567	CcSEcCtD
Docetaxel—CYP3A4—central nervous system—brain cancer	8.22e-05	0.00113	CbGeAlD
Docetaxel—Anorexia—Etoposide—brain cancer	8.08e-05	0.000557	CcSEcCtD
Docetaxel—Hypersensitivity—Carmustine—brain cancer	8.07e-05	0.000557	CcSEcCtD
Docetaxel—Nausea—Hydroxyurea—brain cancer	8.05e-05	0.000555	CcSEcCtD
Docetaxel—ABCB1—medulla oblongata—brain cancer	8.04e-05	0.0011	CbGeAlD
Docetaxel—Hypotension—Etoposide—brain cancer	7.92e-05	0.000546	CcSEcCtD
Docetaxel—Asthenia—Carmustine—brain cancer	7.86e-05	0.000542	CcSEcCtD
Docetaxel—Hypersensitivity—Temozolomide—brain cancer	7.8e-05	0.000538	CcSEcCtD
Docetaxel—Paraesthesia—Etoposide—brain cancer	7.61e-05	0.000525	CcSEcCtD
Docetaxel—Asthenia—Temozolomide—brain cancer	7.6e-05	0.000524	CcSEcCtD
Docetaxel—Dyspnoea—Etoposide—brain cancer	7.56e-05	0.000521	CcSEcCtD
Docetaxel—Somnolence—Etoposide—brain cancer	7.53e-05	0.000519	CcSEcCtD
Docetaxel—Diarrhoea—Carmustine—brain cancer	7.5e-05	0.000517	CcSEcCtD
Docetaxel—Pruritus—Temozolomide—brain cancer	7.49e-05	0.000517	CcSEcCtD
Docetaxel—Decreased appetite—Etoposide—brain cancer	7.37e-05	0.000508	CcSEcCtD
Docetaxel—ABCB1—midbrain—brain cancer	7.35e-05	0.00101	CbGeAlD
Docetaxel—Gastrointestinal disorder—Etoposide—brain cancer	7.32e-05	0.000504	CcSEcCtD
Docetaxel—Fatigue—Etoposide—brain cancer	7.31e-05	0.000504	CcSEcCtD
Docetaxel—Dizziness—Carmustine—brain cancer	7.25e-05	0.0005	CcSEcCtD
Docetaxel—Constipation—Etoposide—brain cancer	7.25e-05	0.0005	CcSEcCtD
Docetaxel—Pain—Etoposide—brain cancer	7.25e-05	0.0005	CcSEcCtD
Docetaxel—Diarrhoea—Temozolomide—brain cancer	7.25e-05	0.000499	CcSEcCtD
Docetaxel—ABCB1—spinal cord—brain cancer	7.17e-05	0.000983	CbGeAlD
Docetaxel—Dizziness—Temozolomide—brain cancer	7e-05	0.000483	CcSEcCtD
Docetaxel—Feeling abnormal—Etoposide—brain cancer	6.98e-05	0.000481	CcSEcCtD
Docetaxel—Vomiting—Carmustine—brain cancer	6.97e-05	0.00048	CcSEcCtD
Docetaxel—Gastrointestinal pain—Etoposide—brain cancer	6.93e-05	0.000478	CcSEcCtD
Docetaxel—Rash—Carmustine—brain cancer	6.91e-05	0.000476	CcSEcCtD
Docetaxel—Dermatitis—Carmustine—brain cancer	6.9e-05	0.000476	CcSEcCtD
Docetaxel—Headache—Carmustine—brain cancer	6.87e-05	0.000473	CcSEcCtD
Docetaxel—Vomiting—Temozolomide—brain cancer	6.73e-05	0.000464	CcSEcCtD
Docetaxel—Body temperature increased—Etoposide—brain cancer	6.7e-05	0.000462	CcSEcCtD
Docetaxel—Abdominal pain—Etoposide—brain cancer	6.7e-05	0.000462	CcSEcCtD
Docetaxel—Rash—Temozolomide—brain cancer	6.68e-05	0.00046	CcSEcCtD
Docetaxel—Dermatitis—Temozolomide—brain cancer	6.67e-05	0.00046	CcSEcCtD
Docetaxel—Headache—Temozolomide—brain cancer	6.63e-05	0.000457	CcSEcCtD
Docetaxel—Nausea—Carmustine—brain cancer	6.51e-05	0.000449	CcSEcCtD
Docetaxel—ABCB1—endocrine gland—brain cancer	6.45e-05	0.000885	CbGeAlD
Docetaxel—ABCB1—head—brain cancer	6.37e-05	0.000873	CbGeAlD
Docetaxel—Nausea—Temozolomide—brain cancer	6.29e-05	0.000434	CcSEcCtD
Docetaxel—Hypersensitivity—Etoposide—brain cancer	6.24e-05	0.00043	CcSEcCtD
Docetaxel—Asthenia—Etoposide—brain cancer	6.08e-05	0.000419	CcSEcCtD
Docetaxel—Pruritus—Etoposide—brain cancer	6e-05	0.000413	CcSEcCtD
Docetaxel—ABCB1—central nervous system—brain cancer	5.82e-05	0.000797	CbGeAlD
Docetaxel—Diarrhoea—Etoposide—brain cancer	5.8e-05	0.0004	CcSEcCtD
Docetaxel—ABCB1—cerebellum—brain cancer	5.68e-05	0.000779	CbGeAlD
Docetaxel—Dizziness—Etoposide—brain cancer	5.6e-05	0.000386	CcSEcCtD
Docetaxel—Vomiting—Etoposide—brain cancer	5.39e-05	0.000371	CcSEcCtD
Docetaxel—Rash—Etoposide—brain cancer	5.34e-05	0.000368	CcSEcCtD
Docetaxel—Dermatitis—Etoposide—brain cancer	5.34e-05	0.000368	CcSEcCtD
Docetaxel—Headache—Etoposide—brain cancer	5.31e-05	0.000366	CcSEcCtD
Docetaxel—Nausea—Etoposide—brain cancer	5.03e-05	0.000347	CcSEcCtD
Docetaxel—ABCB1—brain—brain cancer	4.62e-05	0.000633	CbGeAlD
Docetaxel—EGFR—Signaling by FGFR in disease—ERBB2—brain cancer	2.32e-05	0.000271	CbGpPWpGaD
Docetaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	2.32e-05	0.000271	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	2.3e-05	0.000269	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—IRS2—brain cancer	2.3e-05	0.000269	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—SKP2—brain cancer	2.3e-05	0.000269	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—ERBB2—brain cancer	2.3e-05	0.000268	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—ERBB2—brain cancer	2.28e-05	0.000266	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—MYC—brain cancer	2.27e-05	0.000265	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—ERBB2—brain cancer	2.27e-05	0.000265	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IRS2—brain cancer	2.22e-05	0.000259	CbGpPWpGaD
Docetaxel—GHRHR—Signaling by GPCR—EGFR—brain cancer	2.19e-05	0.000256	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—ERBB2—brain cancer	2.19e-05	0.000256	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	2.19e-05	0.000256	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.18e-05	0.000255	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—CDKN2A—brain cancer	2.16e-05	0.000253	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—IDH1—brain cancer	2.16e-05	0.000252	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—RELA—brain cancer	2.16e-05	0.000252	CbGpPWpGaD
Docetaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.15e-05	0.000251	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CDK4—brain cancer	2.15e-05	0.000251	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—ERBB2—brain cancer	2.14e-05	0.000251	CbGpPWpGaD
Docetaxel—EGFR—Signaling by SCF-KIT—STAT3—brain cancer	2.12e-05	0.000248	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CYP2C9—brain cancer	2.09e-05	0.000244	CbGpPWpGaD
Docetaxel—NR1I2—Generic Transcription Pathway—MYC—brain cancer	2.06e-05	0.000241	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	2.05e-05	0.00024	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle, Mitotic—CCND1—brain cancer	2.04e-05	0.000239	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.03e-05	0.000237	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	2.03e-05	0.000237	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—IL2—brain cancer	2.02e-05	0.000236	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP2C9—brain cancer	2.02e-05	0.000236	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—CDKN2A—brain cancer	2e-05	0.000234	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	1.99e-05	0.000233	CbGpPWpGaD
Docetaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	1.98e-05	0.000232	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	1.97e-05	0.00023	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—CCND1—brain cancer	1.93e-05	0.000226	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.93e-05	0.000225	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—CTNNB1—brain cancer	1.92e-05	0.000224	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.91e-05	0.000223	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—STAT3—brain cancer	1.91e-05	0.000223	CbGpPWpGaD
Docetaxel—EGFR—EGF/EGFR Signaling Pathway—STAT3—brain cancer	1.9e-05	0.000222	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—RELA—brain cancer	1.88e-05	0.000219	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—ERBB2—brain cancer	1.87e-05	0.000218	CbGpPWpGaD
Docetaxel—EGFR—Spinal Cord Injury—TP53—brain cancer	1.87e-05	0.000218	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—MYC—brain cancer	1.87e-05	0.000218	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTCH2—brain cancer	1.85e-05	0.000216	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP2C9—brain cancer	1.84e-05	0.000215	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CDKN2A—brain cancer	1.83e-05	0.000214	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.83e-05	0.000214	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—CCND1—brain cancer	1.83e-05	0.000213	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—VAV1—brain cancer	1.83e-05	0.000213	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IDH1—brain cancer	1.82e-05	0.000213	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP2C9—brain cancer	1.82e-05	0.000213	CbGpPWpGaD
Docetaxel—BCL2—Immune System—VAV1—brain cancer	1.8e-05	0.00021	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CDKN2A—brain cancer	1.79e-05	0.000209	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HES5—brain cancer	1.79e-05	0.000209	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HES1—brain cancer	1.78e-05	0.000208	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—BSG—brain cancer	1.78e-05	0.000208	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—STAT3—brain cancer	1.77e-05	0.000206	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.76e-05	0.000206	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—VAV1—brain cancer	1.75e-05	0.000205	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.74e-05	0.000203	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STRADA—brain cancer	1.74e-05	0.000203	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HEY1—brain cancer	1.73e-05	0.000202	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—STAT3—brain cancer	1.73e-05	0.000202	CbGpPWpGaD
Docetaxel—EGFR—Disease—IDH1—brain cancer	1.72e-05	0.000201	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—BSG—brain cancer	1.72e-05	0.000201	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—VEGFA—brain cancer	1.72e-05	0.000201	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—MYC—brain cancer	1.71e-05	0.0002	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ENO2—brain cancer	1.71e-05	0.0002	CbGpPWpGaD
Docetaxel—ABCC1—Disease—DLL1—brain cancer	1.7e-05	0.000198	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—brain cancer	1.69e-05	0.000198	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL2—brain cancer	1.69e-05	0.000198	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—VEGFA—brain cancer	1.69e-05	0.000197	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.68e-05	0.000196	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CCND1—brain cancer	1.65e-05	0.000193	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle, Mitotic—MYC—brain cancer	1.64e-05	0.000191	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CDKN2A—brain cancer	1.64e-05	0.000191	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—CTNNB1—brain cancer	1.63e-05	0.000191	CbGpPWpGaD
Docetaxel—EGFR—Disease—HEY1—brain cancer	1.63e-05	0.00019	CbGpPWpGaD
Docetaxel—EGFR—Direct p53 effectors—TP53—brain cancer	1.63e-05	0.00019	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—SHH—brain cancer	1.61e-05	0.000188	CbGpPWpGaD
Docetaxel—EGFR—Disease—DLL1—brain cancer	1.6e-05	0.000187	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—RELA—brain cancer	1.59e-05	0.000186	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—ERBB2—brain cancer	1.58e-05	0.000184	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	1.57e-05	0.000183	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—BSG—brain cancer	1.56e-05	0.000183	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—TRPC6—brain cancer	1.55e-05	0.000181	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—BSG—brain cancer	1.55e-05	0.000181	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—brain cancer	1.55e-05	0.000181	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.55e-05	0.00018	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—RELA—brain cancer	1.53e-05	0.000179	CbGpPWpGaD
Docetaxel—EGFR—Integrated Breast Cancer Pathway—TP53—brain cancer	1.53e-05	0.000179	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—IDH1—brain cancer	1.53e-05	0.000178	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PTCH1—brain cancer	1.53e-05	0.000178	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—SMO—brain cancer	1.53e-05	0.000178	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—ERBB2—brain cancer	1.52e-05	0.000178	CbGpPWpGaD
Docetaxel—TUBB2B—Metabolism of proteins—CTNNB1—brain cancer	1.52e-05	0.000178	CbGpPWpGaD
Docetaxel—TUBB6—Metabolism of proteins—CTNNB1—brain cancer	1.52e-05	0.000178	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—CCND1—brain cancer	1.51e-05	0.000177	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.51e-05	0.000176	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—PDGFRA—brain cancer	1.5e-05	0.000175	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—IDH1—brain cancer	1.48e-05	0.000173	CbGpPWpGaD
Docetaxel—BCL2—Immune System—PDGFRA—brain cancer	1.47e-05	0.000172	CbGpPWpGaD
Docetaxel—TUBB3—Metabolism of proteins—CTNNB1—brain cancer	1.47e-05	0.000172	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—MYC—brain cancer	1.47e-05	0.000171	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ABR—brain cancer	1.45e-05	0.000169	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ENO2—brain cancer	1.44e-05	0.000168	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SHH—brain cancer	1.44e-05	0.000168	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—VEGFA—brain cancer	1.44e-05	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—PDGFRA—brain cancer	1.44e-05	0.000168	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—ERBB2—brain cancer	1.43e-05	0.000167	CbGpPWpGaD
Docetaxel—TUBB2A—Metabolism of proteins—CTNNB1—brain cancer	1.42e-05	0.000166	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—STAT3—brain cancer	1.42e-05	0.000166	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.42e-05	0.000166	CbGpPWpGaD
Docetaxel—EGFR—MAPK Signaling Pathway—TP53—brain cancer	1.41e-05	0.000164	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GLI2—brain cancer	1.4e-05	0.000164	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SKP2—brain cancer	1.4e-05	0.000163	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CDK4—brain cancer	1.4e-05	0.000163	CbGpPWpGaD
Docetaxel—TUBB1—Metabolism of proteins—CTNNB1—brain cancer	1.39e-05	0.000163	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—CCND1—brain cancer	1.39e-05	0.000162	CbGpPWpGaD
Docetaxel—EGFR—Disease—SHH—brain cancer	1.36e-05	0.000159	CbGpPWpGaD
Docetaxel—EGFR—Disease—ENO2—brain cancer	1.36e-05	0.000159	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—MYC—brain cancer	1.36e-05	0.000159	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—IDH1—brain cancer	1.34e-05	0.000157	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—IDH1—brain cancer	1.33e-05	0.000156	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—CTNNB1—brain cancer	1.33e-05	0.000156	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MYC—brain cancer	1.32e-05	0.000155	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP2C9—brain cancer	1.32e-05	0.000154	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GLI1—brain cancer	1.32e-05	0.000154	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IRS2—brain cancer	1.31e-05	0.000153	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—EGFR—brain cancer	1.29e-05	0.000151	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IRS2—brain cancer	1.29e-05	0.000151	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.27e-05	0.000148	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—IRS2—brain cancer	1.26e-05	0.000147	CbGpPWpGaD
Docetaxel—TUBB4A—Metabolism of proteins—CTNNB1—brain cancer	1.25e-05	0.000146	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SUFU—brain cancer	1.25e-05	0.000146	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.24e-05	0.000145	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—MYC—brain cancer	1.24e-05	0.000145	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—MYC—brain cancer	1.21e-05	0.000142	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ENO2—brain cancer	1.21e-05	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GFAP—brain cancer	1.2e-05	0.000141	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—STAT3—brain cancer	1.2e-05	0.000141	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—TP53—brain cancer	1.2e-05	0.000141	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.2e-05	0.000141	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.18e-05	0.000138	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ENO2—brain cancer	1.17e-05	0.000136	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—VAV1—brain cancer	1.16e-05	0.000136	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CTNNB1—brain cancer	1.14e-05	0.000134	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HEY1—brain cancer	1.14e-05	0.000133	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—BSG—brain cancer	1.12e-05	0.000131	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—DLL1—brain cancer	1.12e-05	0.000131	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MYC—brain cancer	1.11e-05	0.00013	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.1e-05	0.000129	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—VEGFA—brain cancer	1.1e-05	0.000129	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TP53—brain cancer	1.09e-05	0.000127	CbGpPWpGaD
Docetaxel—EGFR—Immune System—VAV1—brain cancer	1.06e-05	0.000124	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ENO2—brain cancer	1.06e-05	0.000124	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—EGFR—brain cancer	1.06e-05	0.000123	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ENO2—brain cancer	1.05e-05	0.000123	CbGpPWpGaD
Docetaxel—ABCC1—Disease—VAV1—brain cancer	1.04e-05	0.000122	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—RELA—brain cancer	1.03e-05	0.00012	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—ERBB2—brain cancer	1.02e-05	0.000119	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—TP53—brain cancer	9.98e-06	0.000117	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP2C9—brain cancer	9.94e-06	0.000116	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—MYC—brain cancer	9.94e-06	0.000116	CbGpPWpGaD
Docetaxel—EGFR—Disease—VAV1—brain cancer	9.82e-06	0.000115	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	9.73e-06	0.000114	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—IDH1—brain cancer	9.63e-06	0.000113	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	9.63e-06	0.000112	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SHH—brain cancer	9.52e-06	0.000111	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TRPC6—brain cancer	9.18e-06	0.000107	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—TP53—brain cancer	9.13e-06	0.000107	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—RELA—brain cancer	9.06e-06	0.000106	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SMO—brain cancer	9.03e-06	0.000105	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTCH1—brain cancer	9.03e-06	0.000105	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—ERBB2—brain cancer	9.01e-06	0.000105	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HES1—brain cancer	8.96e-06	0.000105	CbGpPWpGaD
Docetaxel—BCL2—Immune System—RELA—brain cancer	8.93e-06	0.000104	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—CTNNB1—brain cancer	8.92e-06	0.000104	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ERBB2—brain cancer	8.87e-06	0.000104	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PDGFRA—brain cancer	8.71e-06	0.000102	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—RELA—brain cancer	8.7e-06	0.000102	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ERBB2—brain cancer	8.65e-06	0.000101	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PDGFRA—brain cancer	8.53e-06	9.97e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.48e-06	9.9e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—BSG—brain cancer	8.45e-06	9.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HES1—brain cancer	8.45e-06	9.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PDGFRA—brain cancer	8.04e-06	9.39e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL2—brain cancer	8.04e-06	9.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—CTNNB1—brain cancer	7.88e-06	9.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—VEGFA—brain cancer	7.85e-06	9.17e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PIK3CG—brain cancer	7.84e-06	9.15e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.8e-06	9.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—STAT3—brain cancer	7.78e-06	9.08e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CTNNB1—brain cancer	7.76e-06	9.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IRS2—brain cancer	7.65e-06	8.93e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.63e-06	8.91e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ENO2—brain cancer	7.62e-06	8.89e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IRS2—brain cancer	7.49e-06	8.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—PIK3CG—brain cancer	7.39e-06	8.63e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—IDH1—brain cancer	7.27e-06	8.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOTCH2—brain cancer	7.22e-06	8.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IRS2—brain cancer	7.06e-06	8.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VAV1—brain cancer	6.88e-06	8.03e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—STAT3—brain cancer	6.77e-06	7.9e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—APC—brain cancer	6.62e-06	7.73e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.41e-06	7.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—APC—brain cancer	6.24e-06	7.28e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—EGFR—brain cancer	6.15e-06	7.18e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2C9—brain cancer	6.13e-06	7.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HES1—brain cancer	5.92e-06	6.91e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ENO2—brain cancer	5.75e-06	6.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PDGFRA—brain cancer	5.63e-06	6.58e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3CG—brain cancer	5.54e-06	6.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SPP1—brain cancer	5.47e-06	6.39e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3CG—brain cancer	5.36e-06	6.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RELA—brain cancer	5.28e-06	6.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ERBB2—brain cancer	5.25e-06	6.13e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—BSG—brain cancer	5.21e-06	6.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL2—brain cancer	5.2e-06	6.08e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ERBB2—brain cancer	5.14e-06	6e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IRS2—brain cancer	4.95e-06	5.78e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3CG—brain cancer	4.88e-06	5.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—ERBB2—brain cancer	4.84e-06	5.66e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3CG—brain cancer	4.83e-06	5.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL2—brain cancer	4.75e-06	5.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CTNNB1—brain cancer	4.59e-06	5.36e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CTNNB1—brain cancer	4.5e-06	5.25e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—IDH1—brain cancer	4.48e-06	5.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3CG—brain cancer	4.37e-06	5.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APC—brain cancer	4.37e-06	5.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CTNNB1—brain cancer	4.24e-06	4.95e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—STAT3—brain cancer	4e-06	4.67e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—STAT3—brain cancer	3.92e-06	4.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—STAT3—brain cancer	3.69e-06	4.31e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—brain cancer	3.64e-06	4.25e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—brain cancer	3.56e-06	4.16e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ENO2—brain cancer	3.54e-06	4.14e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3CG—brain cancer	3.49e-06	4.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—brain cancer	3.43e-06	4.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RELA—brain cancer	3.41e-06	3.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ERBB2—brain cancer	3.39e-06	3.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL2—brain cancer	3.07e-06	3.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCND1—brain cancer	3e-06	3.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CTNNB1—brain cancer	2.97e-06	3.47e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3CG—brain cancer	2.64e-06	3.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—brain cancer	2.61e-06	3.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—STAT3—brain cancer	2.59e-06	3.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—brain cancer	2.4e-06	2.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TP53—brain cancer	1.97e-06	2.3e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3CG—brain cancer	1.62e-06	1.9e-05	CbGpPWpGaD
